Robuta

Nov 21, 2025 - Teva’s challenge against Medicare negotiations fell flat in DC federal court, marking another loss for the pharma industry.

Exorbitant drug prices burden American patients and taxpayers in an unfree market

Nov 24, 2025 - US-UK drug pricing deal nears completion, may include VPAG rate reduction to 19% and UK paying more for medicines. Trade envoy Jamieson Greer met with UK...

Jun 16, 2025 - Taxpayers and charities helped develop Zolgensma. Then it debuted at a record price, ushering in a new class of wildly expensive drugs. Its story upends the...

Jan 16, 2026 - While codifying most-favored-nation drug pricing could be helpful for bringing more transparency to these arrangements and guaranteeing that drug companies...

Oct 2, 2025 - US delays pharma tariffs, urging companies to relocate production or lower prices.

May 6, 2025 - Home HEALTH COSTS AND VALUE PRESCRIPTION DRUG PRICING TOPIC Prescription Drug Pricing Drug Pricing Center...

Dec 8, 2025 - Clascoterone: Male pattern baldness, androgenic alopecia, is one of the most common forms of hair loss among men, often appearing in their late 20s or early...

Nov 7, 2025 - Novo Nordisk and Eli Lilly cut U.S. GLP-1 weight-loss drug prices, aiming for higher volumes despite near-term sales impact.

While Trump's strategy to lower prices is a step in the right direction, only Congress can deliver comprehensive reform that benefits all Americans

Oct 30, 2025 - Consumers will soon be able to pick up single-dose vials of the weight loss drug Zepbound at Walmart pharmacies.

Oct 16, 2025 - Meanwell chatted about the evolving obesity drug market, and the continued need for drugs to treat diseases with large prevalence.

Sep 6, 2023 - This article explores the evolving PBM landscape, PhRMA's stance, and the impact of Amazon Pharmacy on drug pricing transparency.

Sep 18, 2025 - CAN strongly opposes any Medicaid proposals that adopt a “most-favored nation” drug pricing model, which would tie U.S. drug prices to those in foreign...

January 7th 2019 | 7:00am - 8:30am | Grand Hyatt SF

<p>WILKES-BARRE — U.S. Rep. Dan Meuser, R-Dallas, this week highlighted progress under the Trump Administration to lower prescription drug prices,...

Nov 20, 2025 - Most Favored Nation drug pricing would limit access to medicines, increase caregiver burden, and stall innovation. Learn why MFN fails patients and caregivers.

Explore how Most Favored Nation drug pricing impacts patient access. Also learn strategies for navigating these challenges. Read the article for insights.

Feb 20, 2026

Nov 7, 2025 - The current attacks on PBMs stem from a misunderstanding of the basis of drug pricing and business expenses.

Sep 30, 2025 - Friendship, threats, and high-stakes negotiation: Pfizer’s Oval Office deal with Trump could slash drug costs and reset U.S. pharma’s balance of power.

A series of STAT articles looking at how pharmaceutical drug pricing is impacted by lobbying and big pharma campaign donations.

Apr 15, 2025 - This report summarizes what states are learning from reporting required by prescription drug price transparency...

Jan 6, 2026 - Mitchell created Patients for Affordable Drugs to raise awareness of the increasingly dire circumstances confronting many Americans.

Dec 19, 2025 - Three experts joined Larry Levitt, executive vice president for health policy at KFF, for a discussion about the latest developments in prescription drug...